We are live on ! Find out more
TMDX icon

Transmedics

200 hedge funds and large institutions have $1.77B invested in Transmedics in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 77 increasing their positions, 66 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 11

151% more call options, than puts

Call options by funds: $19.5M | Put options by funds: $7.77M

125% more funds holding in top 10

Funds holding in top 10: 49 (+5)

50% more capital invested

Capital invested by funds: $1.18B → $1.77B (+$592M)

17% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 66

12% more funds holding

Funds holding: 179200 (+21)

0.33% more ownership

Funds ownership: 90.48%90.81% (+0.33%)

Holders
200
Holders Change
+21
Holders Change %
+11.73%
% of All Funds
3.21%
Holding in Top 10
9
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+125%
% of All Funds
0.14%
New
36
Increased
77
Reduced
66
Closed
11
Calls
$19.5M
Puts
$7.77M
Net Calls
+$11.7M
Net Calls Change
+$1.99M
Name Holding Trade Value Shares
Change
Change in
Stake
FAM
26
Fred Alger Management
New York
$18.5M -$7.21M -135,643 -31%
NIP
27
Nicholas Investment Partners
California
$17.9M +$642K +12,079 +4%
FLAM
28
First Light Asset Management
Minnesota
$16.4M +$5.92M +111,328 +72%
Baillie Gifford & Co
29
Baillie Gifford & Co
United Kingdom
$15.6M +$11.6M +218,048 +618%
KLC
30
Kent Lake Capital
Nevada
$15.4M
Citadel Advisors
31
Citadel Advisors
Florida
$15.3M +$5.58M +104,965 +74%
Charles Schwab
32
Charles Schwab
California
$14.4M +$401K +7,540 +3%
Axa
33
Axa
France
$12.8M -$6.78M -127,600 -38%
Bank of America
34
Bank of America
North Carolina
$12.1M -$947K -17,820 -8%
RA
35
Royce & Associates
New York
$11.9M +$2.13M +40,000 +26%
ACH
36
ArrowMark Colorado Holdings
Colorado
$9.1M -$2.81M -52,945 -26%
Millennium Management
37
Millennium Management
New York
$8.82M +$3.48M +65,469 +84%
PCM
38
Peregrine Capital Management
Minnesota
$8.32M -$217K -4,074 -3%
CM
39
Castleark Management
Illinois
$8.1M +$693K +13,030 +11%
Ameriprise
40
Ameriprise
Minnesota
$7.84M +$2.94M +55,299 +77%
Goldman Sachs
41
Goldman Sachs
New York
$7.54M -$2.7M -50,732 -29%
Voloridge Investment Management
42
Voloridge Investment Management
Florida
$7.19M -$1.61M -30,313 -21%
Russell Investments Group
43
Russell Investments Group
United Kingdom
$6.84M +$83.9K +1,579 +1%
LCG
44
Lisanti Capital Growth
New York
$6.37M
Balyasny Asset Management
45
Balyasny Asset Management
Illinois
$6.07M +$5.23M +98,301 New
N
46
Nuveen
North Carolina
$5.88M -$993K -18,687 -16%
PVI
47
Pura Vida Investments
New York
$5.55M -$1.59M -30,000 -25%
SAM
48
Silvercrest Asset Management
New York
$5.48M -$2.47M -46,551 -34%
EGI
49
EAM Global Investors
California
$5.25M +$1.03M +19,342 +29%
BAM
50
Bullseye Asset Management
Colorado
$5.12M +$71.4K +1,343 +2%

TMDX Hedge Fund Activity: Q4 2022 in Review

200 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q4 2022, worth a combined $1.77B — up 50% from $1.18B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new TMDX positions and 11 closed out — a net gain of 25 holders — while 77 added to existing stakes and 66 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $22.1M. The largest seller was Fidelity Investments, cutting an estimated $35.3M.

  • 200 institutional investors held Transmedics (TMDX) as of Q4 2022, up from 179 in Q3 2022.
  • Funds reported $1.77B of Transmedics stock for Q4 2022, up 50% quarter-over-quarter.
  • 36 funds opened new Transmedics positions in Q4 2022 and 11 closed out, a net change of +25 holders.
  • The largest Transmedics buyer in Q4 2022 was Lord, Abbett & Co, an estimated $22.1M added.
  • The largest Transmedics seller in Q4 2022 was Fidelity Investments, an estimated $35.3M sold.

Based on aggregated 13F filings for Q4 2022.